Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,262 | -84,134 | -84,043 | -54,920 | -30,324 |
| Depreciation Amortization | 2,412 | 10,247 | 7,503 | 4,772 | 2,312 |
| Accounts receivable | 7,909 | -6,671 | -1,371 | -3,528 | 1,316 |
| Accounts payable and accrued liabilities | -4,129 | 1,713 | 1,454 | 685 | 2,075 |
| Other Working Capital | 101,657 | -3,004 | 3,748 | -1,178 | -1,666 |
| Other Operating Activity | -33,748 | 3,537 | 12,577 | 11,297 | 974 |
| Operating Cash Flow | $75,363 | $-78,312 | $-60,132 | $-42,872 | $-25,313 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,210 | 64,883 | 68,150 | 47,662 | 39,237 |
| PPE Investments | -117 | -2,836 | -2,695 | -1,866 | -1,253 |
| Investing Cash Flow | $-54,327 | $62,047 | $65,455 | $45,796 | $37,984 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 199 | 8,548 | 8,417 | 8,090 | 6,690 |
| Other Financing Activity | 34,000 | 18,000 | 0 | 0 | 0 |
| Financing Cash Flow | $18,199 | $26,548 | $8,417 | $8,090 | $6,690 |
| Beginning Cash Position | 33,627 | 23,644 | 23,344 | 23,344 | 23,344 |
| End Cash Position | 72,862 | 33,927 | 37,084 | 34,358 | 42,705 |
| Net Cash Flow | $39,235 | $10,283 | $13,740 | $11,014 | $19,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | 75,363 | -78,312 | -60,132 | -42,872 | -25,313 |
| Capital Expenditure | -117 | -2,836 | -2,695 | -1,866 | -1,253 |
| Free Cash Flow | 75,246 | -81,148 | -62,827 | -44,738 | -26,566 |